The Cancer and Cognition Platform and the COVIPACT study

The François Baclesse center launched in April 2020 a clinical study aimed at studying the impact of the COVID-19 epidemic on the care of patients with solid or hematological cancer, as well as its psychological consequences for patients and caregivers. The study included 735 patients and 73 caregivers (ongoing follow-up).

The Cancer and Cognition platform is involved in the study and will evaluate the psychological and cognitive impact as well as post-traumatic stress.

The COVIPACT study has already been the subject of several scientific articles or in the press: